René Djurup
Director/Board Member at Bioneer A/S
Profile
René Djurup is currently a Director at Bioneer A.
Previously, he worked as the Head of Research & Development at Novo Nordisk A from 1993 to 1997 and as the Chief Technical Officer at Bavarian Nordic A from 2003 to 2008.
He also held a position as Principal at Copenhagen University Hospital.
Dr. Djurup received a graduate degree from the University of Copenhagen in 1987 and a doctorate degree from the same institution in 1978.
René Djurup active positions
Companies | Position | Start |
---|---|---|
Bioneer A/S
Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Director/Board Member | - |
Former positions of René Djurup
Companies | Position | End |
---|---|---|
BAVARIAN NORDIC A/S | Chief Tech/Sci/R&D Officer | 2007-12-31 |
NOVO NORDISK A/S | Chief Tech/Sci/R&D Officer | 1996-12-31 |
Copenhagen University Hospital | Corporate Officer/Principal | - |
Training of René Djurup
University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
NOVO NORDISK A/S | Health Technology |
BAVARIAN NORDIC A/S | Health Technology |
Private companies | 1 |
---|---|
Bioneer A/S
Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Health Technology |
- Stock Market
- Insiders
- René Djurup